Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- Spain
- Denmark
- Sweden
- France
- Portugal
- Poland
- Netherlands
- Canada
- Switzerland
- Australia
- Belgium
- Finland
- Hong Kong
- Czech
- Austria
- Singapore
- Norway
- China
- Italy
- Japan
- Croatia
- Romania
- South Africa
- Brazil
- Luxembourg
- Malta
- Mexico
- Morocco
- New Zealand
- Saudi Arabia
- Taiwan
- 24 more »
- « less
-
Program
-
Field
-
(DC2, DC3, DC12 or DC13) with expected synergies between DC2-DC3 (in vitro models, proteomics methodology) and DC12-DC13 (receptor modelling and engineering). The students will also collaborate with
-
proteomics. Particular emphasis will be placed on the role of the lysosomal protein LIMP-2 in disease progression. The successful candidate will lead this project – planning and performing experiments
-
that combines molecular biology, computational biology, structural biology and chemistry with various ‘Omics’ techniques such as proteomics to study the pathways and protein complexes involved in the regulation
-
, cell biology and infection biology. Project description Biochemical, proteomics and structural studies of apicomplexan parasites and tick-borne RNA viruses. Qualifications The successful candidate shall
-
expected synergies between DC2-DC3 (in vitro models, proteomics methodology) and DC12-DC13 (receptor modelling and engineering). The students will also collaborate with consortium partners
-
. This project will utilise a combination of molecular and cell biology approaches, microbiology and advanced quantitative proteomic methods. ZDHHC5 knockout cells will be used to study the perturbed cell surface
-
facilities. This role will be central to building and integrating our core facility expertise in spatial technologies to generate combined spatial omic methodologies. These include transcriptomics, proteomics
-
(certificates should be submitted in English) and contact details of at least two referees through this form https://www.um.edu.mt/hrmd/workatum-projects by not later than Thursday, 22nd January 2026. Late
-
data/open science, life sciences data systems, and analysis of various kinds of ‘omics data (e.g., metabolomics, proteomics, genomics, transcriptomics, etc.). Values & Abilities: We expect ML Performance
-
handling and culturing, surgical implantation of brain cancer, cryo-electron microscopy, transcriptome, proteome, single cell sequencing and bioinformatics, iPSC derived cells, tissue organoids and/or tissue